CD86 and neoplasm: It is noteworthy that the PTA-expanded Vγ2Vδ2 T cells expressed antigen-presenting cell-related molecules like CD86, HLA-DR, and HLA-DQ, suggesting that tumor antigen-presentation by Vγ2Vδ2 T cells are expected after killing of tumor cells.